Duru Namik Kemal, Cincik Mehmet, Dede Murat, Hasimi Adnan, Baser Iskender
Department of Obstetrics and Gynecology, GATA School of Medicine, Ankara, Turkey.
J Reprod Med. 2007 Sep;52(9):858-63.
Different ovulation trigger methods such as gonadotropin releasing hormone-agonist (GnRH-a) and recombinant human chorionic gonadotropin (r-hCG) plus rescue oocyte retrieval might reveal oocytes in patients with recurrent empty follicle syndrome.
Endogenous luteinizing hormone was triggered with a GnRH-a (Buserelin [Suprefact pro-injection, Aventis-Pharma, Turkey], 250 microg subcutaneously) in a GnRH antagonist (Cetrorelix [Cetrotide 0.25, SeronoTurkey], 0.25 mg/d, starting on day 6), down-regulated cycle. At the first scheduled retrieval, 3 cumulus-oocytecorona complexes were recovered from the left ovary. During chemical denudation with hyaluronidase, 2 of them underwent lysis. The third was a zona-free, germinalvesicle-stage oocyte after mechanical denudation. Oocyte pickup was stopped, and recombinant human chorionic gonadotropin (hCG) (250 microg subcutaneously) was injected. Five cumulus-oocyte-corona complexes were retrieved from the right ovary 24 hours after rescue with recombinant hCG. Only mechanical denudation was done, and 4 zona-free oocytes with germinal vesicle breakdown were seen. All oocytes underwent intracytoplasmic sperm injection, and none of them were fertilized.
Oocyte maturation defects should be included in etiologic mechanisms for counseling patients with empty follicle syndrome.
不同的排卵触发方法,如促性腺激素释放激素激动剂(GnRH-a)和重组人绒毛膜促性腺激素(r-hCG)加补救性取卵,可能会使反复出现空卵泡综合征的患者获得卵母细胞。
在使用GnRH拮抗剂(西曲瑞克[思则凯0.25,雪兰诺土耳其公司],0.25mg/d,从第6天开始)的降调节周期中,使用GnRH-a(布舍瑞林[Suprefact预充式注射剂,安万特制药,土耳其],250μg皮下注射)触发内源性黄体生成素。在首次预定取卵时,从左卵巢回收了3个卵丘-卵母细胞-透明带复合体。在用透明质酸酶进行化学去透明带处理时,其中2个发生溶解。第三个是机械去透明带后无透明带的生发泡期卵母细胞。停止取卵,并皮下注射重组人绒毛膜促性腺激素(hCG)(250μg)。在用重组hCG补救24小时后,从右卵巢回收了5个卵丘-卵母细胞-透明带复合体。仅进行了机械去透明带处理,可见4个有生发泡破裂的无透明带卵母细胞。所有卵母细胞均进行了卵胞浆内单精子注射,但无一受精。
卵母细胞成熟缺陷应纳入空卵泡综合征患者咨询的病因机制中。